Search
Fortress Biotech Inc
FBIOAdd to Watchlist
2.320USD
-0.020-0.85%
Market hours 09/24, 10:57（ET）
77.07MMarket Cap
0.60P/E TTM
Fortress Biotech Inc (FBIO) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Fortress Biotech Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
5.000USD+104.08%
FBIO Analyst Recommendation Trends
In the current month, FBIO has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. FBIO average Analyst price target in the last month is 5.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
FBIO Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, FBIO EPS is projected to reach -0.270 in FY2026Q3, following reported EPS of -0.078 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.11
-0.22
-0.20
-0.27
-0.25
Actual
-0.20
3.44
-0.08
--
--
Surprise
-285.45%
+1661.70%
+61.06%
--
--
FAQs
What is Fortress Biotech Inc's expected revenue for the next quarter?
Fortress Biotech Inc's expected revenue is 21.57M.
What is Fortress Biotech Inc's price target?
Analysts forecast that Fortress Biotech Inc's price target is USD 5.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 5.00.
How have Fortress Biotech IncFBIO's recent earnings per share performed?
The market expectation was USD -0.08, while Fortress Biotech IncFBIO's earnings per share (EPS) for the previous quarter was USD 3.44. EPS for the next quarter is expected at USD -0.27.
What is the analyst rating for Fortress Biotech Inc?
Based on the ratings of Fortress Biotech Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.